AFSTYLA Antihemophilic Factor (Recombinant), Single Chain
NDC 69911-475, ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT, kit, from CSL Behring Lengnau AG.
- Product NDC
- 69911-475
- Status
- Listed
- Labeler
- CSL Behring Lengnau AG
- Dosage form
- KIT
- Route
- —
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125591
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69911-475 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69911-475-02 | 69911047502 | 1 KIT in 1 CARTON (69911-475-02) * 2.5 mL in 1 VIAL, SINGLE-USE (69911-765-83) * 2.5 mL in 1 VIAL, SINGLE-USE (69911-485-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=69911-475
Use it
Look up 69911-475 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69911-475 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69911-475. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.